WHO ICTRP trial
Remezepam Ointment treating vitiligo
ChiCTR2300074979 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300074979 |
|---|---|
| Public title | Remezepam Ointment treating vitiligo |
| Scientific title | Clinical Observation on the Treatment of Local Vitiligo with CGRP Receptor Inhibitor Remezepam Ointment |
| Primary sponsor | Third Hospital of Hangzhou |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | vitiligo |
| Interventions | Group of topical:Remezepam ointment for external use;Group of topical with phototherapy:Remezepam ointment for external use with phototherapy |
| Registration date | Aug 22, 2023 |
| Target size | Group of topical:20;Group of topical with phototherapy:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: